Professor Oliver Hanemann and his team at our specialist research centre at the University of Plymouth continue to be at the forefront of European research into low-grade brain tumours including meningioma which is the most common form of adult primary brain tumour.
Brain Tumour Research has been funding this Centre of Excellence for the past five years and this level of sustainability enabled by our investment is now bearing fruit with the promise of research papers being published.
Former BBC correspondent and Chair of BBC Children in Need, Rosie Millard MBE, underwent surgery to remove a meningioma after developing tinnitus two years ago.
She said: “I was very fortunate and happy with the care I received following my diagnosis but I am aware that we need to continue to sustainably fund the discovery science that Professor Hanemann and his team undertake so that we continue to learn more about the disease. That is why I am happy to support the work of Brain Tumour Research.”
Speaking about her diagnosis and treatment, she told us: “When I received my diagnosis, I kept thinking: ‘why me?’ I am fit. I run. I eat healthily. I am active. I have four children who depend on me. I soon realised however that this disease is completely indiscriminate. I broke the news to my children over a BBQ in the back garden on the evening of my diagnosis. My kids were really positive and encouraging, telling me that I would be fine. Other than my closest friends and family, I didn’t tell people about my brain tumour until after the operation. It was my way of coping.”
Meningioma develops in the meninges – the membrane that surrounds the brain and spinal cord - and accounts for approximately 30-37% of all adult central nervous system tumours and most are low-grade.
Brain Tumour Research Patron, the supermodel and businesswoman Caprice Bourret was also diagnosed with a meningioma and underwent surgery in the spring of 2017.
Related reading:
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.